Spectral Medical Inc. (TSX: EDT)
Health Care · Biotechnology · CA
CA$1.11
-5.53% today · -20.7% 1Y
Spectral Medical Inc. (TSX: EDT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $228.66M and employs 29 people.
Over the last twelve months the share price has lost 20.7%, trading between 1.03 and 1.65.
Tweenvest scores Spectral Medical Inc. across four factors: quality 17/100, value 46/100, growth 32/100. Its strongest factor is value.
EDT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $228.66M
- Revenue (TTM)
- $1.81M
- P/E
- —
- EPS
- -0.12
- Dividend yield
- —
- Beta (5Y)
- 0.22
- 52-week high
- CA$1.65
- 52-week low
- CA$1.03
- Avg volume (3M)
- —
- Shares outstanding
- 293.93M
- Employees
- 29
- Next earnings
- —
About Spectral Medical Inc.
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
- ISIN
- CA8475771033
- Founded
- 1991
- Listed since
- Aug 13, 1996
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alector, Inc.NasdaqGS: ALEC | $232.25M | $2.07 | -0.48% |
| EuBiologics Co., Ltd.KOSDAQ: A206650 | $230.18M | ₩8,420.00 | -0.36% |
| ProQR Therapeutics N.V.NasdaqCM: PRQR | $230.03M | $1.68 | +3.07% |
| Valerio Therapeutics Société anonymeENXTPA: ALVIO | $229.28M | €0.41 | +7.61% |
| Evommune, Inc.NYSE: EVMN | $226.83M | $6.06 | -3.04% |
| ImmuneOncia Therapeutics, Inc.KOSDAQ: A424870 | $224.36M | ₩3,300.00 | -4.21% |
| Protalix BioTherapeutics, Inc.NYSEAM: PLX | $223.99M | $2.78 | 0.00% |
| ToolGen IncorporatedKOSDAQ: A199800 | $223.81M | ₩33,450.00 | -3.18% |
Figures last refreshed Oct 11, 2026.